May 2009

Articles

ETIOLOGY OF DIABETES

WOMEN'S ENDOCRINOLOGY

COVER STORY

DEPARTMENTS

View All News >
News
Rosiglitazone Discontinuation Left Many Patients Without Good Control

When concerns were raised about the safety of the diabetes medication rosiglitazone (Avandia, GlaxoSmithKline) in May 2007, many patients and their doctors made the decision to discontinue use of the drug. A study published in End... more >

News
Endocrine Society Releases New Guideline on Adult Hypoglycemic Disorders

The Endocrine Society released a new clinical practice guideline for the evaluation and management of adult hypoglycemic disorders. The guideline appears in the Journal of Clinical Endocrinology & Metabolism (JCEM). "Preve... more >

News
Saxagliptin Cardiovascular Profile Acceptable According to FDA Advisory Committee

Bristol-Myers Squibb Company and AstraZeneca announced that the FDA Endocrinologic and Metabolic Drugs Advisory Committee determined that the data supporting the new drug application (NDA) for saxagliptin (Onglyza) for the treatme... more >

News
FDA: Liraglutide Update

Novo Nordisk announced that the Endocrinologic and Metabolic Drugs Advisory Committee of the FDA has finalized its discussions of questions related to liraglutide, a once-daily human glucagon-like peptide 1 analog. The Advisor... more >

TOP 5 ARTICLES FROM MAY 2009